Registro:

Referencias:

• Henry, J.A., Dennis, K.C., Schechter, M.A., General review of tinnitus: Prevalence, mechanisms, effects, and management (2005) J Speech Lang Hear Res, 48 (5), pp. 1204-1235
• Axelsson, A., Ringdahl, A., Tinnitus-a study of its prevalence and characteristics (1989) Br J Audiol, 23 (1), pp. 53-62
• Hoffman, H.J., Reed, G.W., Epidemiology of Tinnitus (2004) Tinnitus: Theory and Management, pp. 16-41. , Snow JB, editor, London: BC Decker
• Vio, M.M., Holme, R.H., Hearing loss and tinnitus: 250 million people and a US$10 billion potential market (2005) Drug Discov Today, 10 (19), pp. 1263-1265
• Norena, A., Micheyl, C., Chery-Croze, S., Collet, L., Psychoacoustic characterization of the tinnitus spectrum: Implications for the underlying mechanisms of tinnitus (2002) Audiol Neurootol, 7 (6), pp. 358-369
• Roberts, L.E., Moffat, G., Bosnyak, D.J., Residual inhibition functions in relation to tinnitus spectra and auditory threshold shift (2006) Acta Otolaryngol Suppl, 556, pp. 27-33
• Konig, O., Schaette, R., Kempter, R., Gross, M., Course of hearing loss and occurrence of tinnitus (2006) Hear Res, 221 (1-2), pp. 59-64
• House, J.W., Brackmann, D.E., Tinnitus: Surgical treatment (1981) Ciba Found Symp, 85, pp. 204-216
• Heller, M.F., Bergman, M., Tinnitus aurium in normally hearing persons (1953) Ann Otol Rhinol Laryngol, 62 (1), pp. 73-83
• Del Bo, L., Forti, S., Ambrosetti, U., Tinnitus aurium in persons with normal hearing: 55 years later (2008) Otolaryngol Head Neck Surg, 139 (3), pp. 391-394
• Langguth, B., Goodey, R., Azevedo, A., Consensus for tinnitus patient assessment and treatment outcome measurement: Tinnitus Research Initiative meeting Regensburg July, 2006 (2007) Prog Brain Res, 166, pp. 525-536
• Henry, J.A., Meikle, M.B., Psychoacoustic measures of tinnitus (2000) J Am Acad Audiol, 11, pp. 138-155
• Vernon, J.A., Meikle, M.B., Tinnitus: Clinical measurement (2003) Otolaryngol Clin North Am, 36 (2), pp. 293-305. , vi
• Tyler, R.S., Oleson, J., Noble, W., Clinical trials for tinnitus: Study populations, designs, measurement variables, and data analysis (2007) Prog Brain Res, 166, pp. 499-509
• Hiller, W., Goebel, G., Factors influencing tinnitus loudness and annoyance (2006) Arch Otolaryngol Head Neck Surg, 132 (12), pp. 1323-1330
• Jastreboff, P.J., Phantom auditory perception (tinnitus): Mechanisms of generation and perception (1990) Neurosci Res, 8, pp. 221-254
• Moller, A.R., Pathophysiology of tinnitus (2003) Otolaryngol Clin North Am, 36, pp. 249-266
• Bauer, C.A., Turner, J.G., Caspary, D.M., Tinnitus and inferior colliculus activity in chinchillas related to three distinct patterns of cochlear trauma (2008) J Neurosci Res, 86 (11), pp. 2564-2578
• Eggermont, J.J., Pathophysiology of tinnitus (2007) Prog Brain Res, 166, pp. 19-35
• Kaltenbach, J.A., The dorsal cochlear nucleus as a contributor to tinnitus: Mechanisms underlying the induction of hyperactivity (2007) Prog Brain Res, 166, pp. 89-106
• Melcher, J.R., Sigalovsky, I.S., Guinan Jr., J.J., Levine, R.A., Lateralized tinnitus studied with functional magnetic resonance imaging: Abnormal inferior colliculus activation (2000) J Neurophysiol, 83, pp. 1058-1072
• Reyes, S.A., Salvi, R.J., Burkard, R.F., Brain imaging of the effects of lidocaine on tinnitus (2002) Hear Res, 171, pp. 43-50
• Langguth, B., Eichhammer, P., Kreutzer, A., The impact of auditory cortex activity on characterizing and treating patients with chronic tinnitus-first results from a PET study (2006) Acta Otolaryngol Suppl, (556), pp. 84-88
• Smits, M., De Rd, K.S., Lateralization of functional magnetic resonance imaging (fMRI) activation in the auditory pathway of patients with lateralized tinnitus (2007) Neuroradiology, 49 (8), pp. 669-679
• Schlee, W., Hartmann, T., Langguth, B., Weisz, N., Abnormal resting-state cortical coupling in chronic tinnitus (2009) BMC Neurosci, 10 (11)
• Muroi, Y., Chanda, B., Local anesthetics disrupt energetic coupling between the voltage-sensing segments of a sodium channel (2009) J Gen Physiol, 133 (1), pp. 1-15
• Trellakis, S., Lautermann, J., Lehnerdt, G., Lidocaine: Neurobiological targets and effects on the auditory system (2007) Prog Brain Res, 166, pp. 303-322
• Cronlein, T., Langguth, B., Geisler, P., Hajak, G., Tinnitus and insomnia (2007) Prog Brain Res, 166, pp. 227-233
• Langguth, B., Kleinjung, T., Fischer, B., Tinnitus severity, depression, and the big five personality traits (2007) Prog Brain Res, 166, pp. 221-225
• Biassoni, E.C., Serra, M.R., Richtert, U., Recreational noise exposure and its effects on the hearing of adolescents (2005) Int J Audiol, 44 (2), pp. 74-85. , Part II: Development of hearing disorders
• Serra, M.R., Biassoni, E.C., Richter, U., Recreational noise exposure and its effects on the hearing of adolescents (2005) Int J Audiol, 44 (2), pp. 65-73. , Part I: An interdisciplinary long-term study
• http://www.vba.va.gov/bln/21/, Available from:; Dobie, R.A., A review of randomized clinical trials in tinnitus (1999) Laryngoscope, 109, pp. 1202-1211
• Dobie, R., Clinical trials and drug therapy for tinnitus (2004) Tinnitus: Theory and Management, pp. 266-277. , Snow JB, editor. Hamilton: BC Decker
• Vio, M., (2003) Tinnitus Market Situation Analysis, , London: RNID
• Eggermont, J.J., Tinnitus: Neurobiological substrates (2005) Drug Discov Today, 10 (19), pp. 1283-1290
• Moller, A.R., Tinnitus and pain (2007) Prog Brain Res, 166, pp. 47-53
• Moller, A.R., A double-blind placebo-controlled trial of baclofen in the treatment of tinnitus (1997) Am J Otol, 18 (2), pp. 268-269
• Barany, R., Die beeinflussung des ohrensausens durch intravenös injizierte lokalanästhetica (1935) Acta Otolarngologica, 23, pp. 201-203
• Melding, P.S., Goodey, R.J., Thorne, P.R., The use of intravenous lignocaine in the diagnosis and treatment of tinnitus (1978) J Laryngol Otol, 92 (2), pp. 115-121
• Martin, F.W., Colman, B.H., Tinnitus: A double-blind crossover controlled trial to evaluate the use of lignocaine (1980) Clin Otolaryngol, 5, pp. 3-11
• Sanchez, T.G., Balbani, A.P., Bittar, R.S., Lidocaine test in patients with tinnitus: Rationale of accomplishment and relation to the treatment with carbamazepine (1999) Auris Nasus Larynx, 26 (4), pp. 411-417
• Trellakis, S., Benzenberg, D., Urban, B.W., Friederich, P., Differential lidocaine sensitivity of human voltage-gated potassium channels relevant to the auditory system (2006) Otol Neurotol, 27 (1), pp. 117-123
• Haginomori, S., Makimoto, K., Araki, M., Effect of lidocaine injection of EOAE in patients with tinnitus (1995) Acta Otolaryngol, 115 (4), pp. 488-492
• Baguley, D.M., Jones, S., Wilkins, I., The inhibitory effect of intravenous lidocaine infusion on tinnitus after translabyrinthine removal of vestibular schwannoma: A double-blind, placebo-controlled, crossover study (2005) Otol Neurotol, 26 (2), pp. 169-176
• Schwartz, M.L., Meyer, M.B., Covino, B.G., Antiarrhythmic effectiveness of intramuscular lidocaine: Influence of different injection sites (1974) J Clin Pharmacol, 14 (2), pp. 77-83
• Clarkson, C.W., Follmer, C.H., Eick, T., Evidence for two components of sodium channel block by lidocaine in isolated cardiac myocytes (1988) Circ Res, 63 (5), pp. 869-878
• Courtney, K.R., Mechanism of frequency-dependent inhibition of sodium currents in frog myelinated nerve by the lidocaine derivative GEA (1975) J Pharmacol Exp Ther, 195 (2), pp. 225-236
• Lenkowski, P.W., Shah, B.S., Dinn, A.E., Lidocaine block of neonatal Nav1.3 is differentially modulated by co-expression of beta1 and beta3 subunits (2003) Eur J Pharmacol, 467 (1-3), pp. 23-30
• Josephson, I.R., Lidocaine blocks Na, Ca and K currents of chick ventricular myocytes (1988) J Mol Cell Cardiol, 20 (7), pp. 593-604
• Plewnia, C., Reimold, M., Najib, A., Dose-dependent attenuation of auditory phantom perception (tinnitus) by PET-guided repetitive transcranial magnetic stimulation (2007) Hum Brain Mapp, 28 (3), pp. 238-246
• Hulshof, J.H., Vermeij, P., The value of tocainide in the treatment of tinnitus (1985) Arch Otorhinolaryngol, 241, pp. 279-283. , A double-blind controlled study
• Blayney, A.W., Phillips, M.S., Guy, A.M., Colman, B.H., A sequential double blind cross-over trial of tocainide hydrochloride in tinnitus (1985) Clin Otolaryngol, 10, pp. 97-101
• Lenarz, Th., Treatment of tinnitus with lidocaine and tocainide (1987) Scandinavian Audiology, SUPPL. 26, pp. 49-51
• Sieghart, W., Pharmacology of benzodiazepine receptors: An update (1994) J Psychiatry Neurosci, 19 (1), pp. 24-29
• Johnson, R.M., Brummett, R., Schleuning, A., (1993) Use of alprazolam for relief of tinnitus, 119 (8), pp. 842-845. , A double-blind study Arch Otolaryngol Head Neck Surg
• Kay, N.J., Oral chemotherapy in tinnitus (1981) Br J Audiol, 15 (2), pp. 123-124
• Gananca, M.M., Caovilla, H.H., Gananca, F.F., Clonazepam in the pharmacological treatment of vertigo and tinnitus (2002) Int Tinnitus J, 8 (1), pp. 50-53
• Bahmad Jr., F.M., Venosa, A.R., Oliveira, C.A., Benzodiazepines and GABAergics in treating severe disabling tinnitus of predominantly cochlear origin (2006) Int Tinnitus J, 12 (2), pp. 140-144
• Busto, U., Fornazzari, L., Naranjo, C.A., Protracted tinnitus after discontinuation of long-term therapeutic use of benzodiazepines (1988) J Clin Psychopharmacol, 8 (5), pp. 359-362
• Busto, U., Sellers, E.M., Naranjo, C.A., Withdrawal reaction after long-term therapeutic use of benzodiazepines (1986) N Engl J Med, 315 (14), pp. 854-859
• Moller, A.R., Similarities between severe tinnitus and chronic pain (2000) J Am Acad Audiol, 11, pp. 115-124
• Gross, G., Xin, X., Gastpar, M., Trimipramine: Pharmacological reevaluation and comparison with clozapine (1991) Neuropharmacology, 30 (11), pp. 1159-1166
• Bayar, N., Boke, B., Turan, E., Belgin, E., Efficacy of amitriptyline in the treatment of subjective tinnitus (2001) J Otolaryngol, 30 (5), pp. 300-303
• Podoshin, L., Ben-David, Y., Fradis, M., Idiopathic subjective tinnitus treated by amitriptyline hydrochloride/biofeedback (1995) Int Tinnitus J, 1 (1), pp. 54-60
• Sullivan, M.D., Dobie, R.A., Sakai, C.S., Katon, W.J., Treatment of depressed tinnitus patients with nortriptyline (1989) Ann Otol Rhinol Laryngol, 98 (11), pp. 867-872
• Sullivan, M., Katon, W., Russo, J., A randomized trial of nortriptyline for severe chronic tinnitus. Effects on depression, disability, and tinnitus symptoms (1993) Arch Intern Med, 153 (19), pp. 2251-2259
• Katon, W., Sullivan, M., Russo, J., Depressive symptoms and measures of disability: A prospective study (1993) J Affect Disord, 27 (4), pp. 245-254
• Mihail, R.C., Crowley, J.M., Walden, B.E., The tricyclic trimipramine in the treatment of subjective tinnitus (1988) Ann Otol Rhinol Laryngol, 97 (2 PART 1), pp. 120-123
• Mendis, D., Johnston, M., An unusual case of prolonged tinnitus following low-dose amitriptyline (2008) J Psychopharmacol, 22 (5), pp. 574-575
• Feder, R., Tinnitus associated with amitriptyline (1990) J Clin Psychiatry, 51 (2), pp. 85-86
• Tandon, R., Grunhaus, L., Greden, J.F., Imipramine and tinnitus (1987) J Clin Psychiatry, 48 (3), pp. 109-111
• Robinson, S.K., Viirre, E.S., Bailey, K.A., Randomized placebo-controlled trial of a selective serotonin reuptake inhibitor in the treatment of nondepressed tinnitus subjects (2005) Psychosom Med, 67 (6), pp. 981-988
• Zoger, S., Svedlund, J., Holgers, K.M., The effects of sertraline on severe tinnitus suffering-a randomized, double-blind, placebo-controlled study (2006) J Clin Psychopharmacol, 26 (1), pp. 32-39
• Robinson, S., Antidepressants for treatment of tinnitus (2007) Prog Brain Res, 166, pp. 263-271
• Willow, M., Gonoi, T., Catterall, W.A., Voltage clamp analysis of the inhibitory actions of diphenylhydantoin and carbamazepine on voltage-sensitive sodium channels in neuroblastoma cells (1985) Mol Pharmacol, 27 (5), pp. 549-558
• Cardenas, C.A., Cardenas, C.G., De Armendi, A.J., Scroggs, R.S., Carbamazepine interacts with a slow inactivation state of NaV1.8-like sodium channels (2006) Neurosci Lett, 408 (2), pp. 129-134
• Shea, J.J., Harell, M., Management of tinnitus aurium with lidocaine and carbamazepine (1978) Laryngoscope, 88 (9 PART 1), pp. 1477-1484
• Melding, P.S., Goodey, R.J., The treatment of tinnitus with oral anticonvulsants (1979) J Laryngol Otol, 93 (2), pp. 111-122
• Donaldson, I., Tegretol: A double blind trial in tinnitus (1981) J Laryngol Otol, 95 (9), pp. 947-951
• Hulshof, J.H., Vermeij, P., The value of carbamazepine in the treatment of tinnitus (1985) ORL J Otorhinolaryngol Relat Spec, 47, pp. 262-266
• Marks, N.J., Onisiphorou, C., Trounce, J.R., The effect of single doses of amylobarbitone sodium and carbamazepine in tinnitus (1981) J Laryngol Otol, 95 (9), pp. 941-945
• Levine, R.A., Typewriter tinnitus: A carbamazepine-responsive syndrome related to auditory nerve vascular compression (2006) ORL J Otorhinolaryngol Relat Spec, 68 (1), pp. 43-46
• Mardini, M.K., Ear-clicking "tinnitus" responding to carbamazepine (1987) N Engl J Med, 317 (24), p. 1542
• Zheng, Y., Hooton, K., Smith, P.F., Darlington, C.L., Carbamazepine reduces the behavioural manifestations of tinnitus following salicylate treatment in rats (2008) Acta Otolaryngol, 128 (1), pp. 48-52
• Zapp, J.J., Gabapentin for the treatment of tinnitus: A case report (2001) Ear Nose Throat J, 80 (2), pp. 114-116
• Shulman, A., Gabapentin and tinnitus relief (2008) Int Tinnitus J, 14 (1), pp. 1-5
• Bauer, C.A., Brozoski, T.J., Assessing tinnitus and prospective tinnitus therapeutics using a psychophysical animal model (2001) J Assoc Res Otolaryngol, 2 (1), pp. 54-64
• Witsell, D.L., Hannley, M.T., Stinnet, S., Tucci, D.L., Treatment of tinnitus with gabapentin: A pilot study (2007) Otol Neurotol, 28 (1), pp. 11-15
• Bakhshaee, M., Ghasemi, M., Azarpazhooh, M., Gabapentin effectiveness on the sensation of subjective idiopathic tinnitus: A pilot study (2008) Eur Arch Otorhinolaryngol, 265 (5), pp. 525-530
• Piccirillo, J.F., Finnell, J., Vlahiotis, A., Relief of idiopathic subjective tinnitus: Is gabapentin effective? (2007) Arch Otolaryngol Head Neck Surg, 133 (4), pp. 390-397
• Bauer, C.A., Brozoski, T.J., Effect of gabapentin on the sensation and impact of tinnitus (2006) Laryngoscope, 116 (5), pp. 675-681
• Brozoski, T.J., Spires, T.J., Bauer, C.A., Vigabatrin, a GABA transaminase inhibitor, reversibly eliminates tinnitus in an animal model (2007) J Assoc Res Otolaryngol, 8 (1), pp. 105-118
• Willmore, L.J., Abelson, M.B., Ben-Menachem, E., Vigabatrin: 2008 update (2009) Epilepsia, 50 (2), pp. 163-173
• Oestreicher, E., Arnold, W., Ehrenberger, K., Felix, D., Memantine suppresses the glutamatergic neurotransmission of mammalian inner hair cells (1998) ORL J Otorhinolaryngol Relat Spec, 60 (1), pp. 18-21
• Guitton, M.J., Caston, J., Ruel, J., Salicylate induces tinnitus through activation of cochlear NMDA receptors (2003) J Neurosci, 23 (9), pp. 3944-3952
• Guitton, M.J., Dudai, Y., Blockade of cochlear NMDA receptors prevents long-term tinnitus during a brief consolidation window after acoustic trauma (2007) Neural Plast, 2007, p. 80904
• Jastreboff, P.J., Brennan, J.F., Coleman, J.K., Sasaki, C.T., Phantom auditory sensation in rats: An animal model for tinnitus (1988) Behav Neurosci, 102 (6), pp. 811-822
• Peng, B.G., Chen, S., Lin, X., Aspirin selectively augmented N-methyl-D-aspartate types of glutamate responses in cultured spiral ganglion neurons of mice (2003) Neurosci Lett, 343 (1), pp. 21-24
• Ehrenberger, K., Felix, D., Receptor pharmacological models for inner ear therapies with emphasis on glutamate receptors: A survey (1995) Acta Otolaryngol, 115, pp. 236-240
• Denk, D.M., Heinzl, H., Franz, P., Ehrenberger, K., Caroverine in tinnitus treatment (1997) Acta Otolaryngol, 117 (6), pp. 825-830. , A placebo-controlled blind study
• Domeisen, H., Hotz, M.A., Hausler, R., Caroverine in tinnitus treatment (1998) Acta Otolaryngol, 118 (4), pp. 606-608
• Rogawski, M.A., Wenk, G.L., The neuropharmacological basis for the use of memantine in the treatment of Alzheimer's disease (2003) CNS Drug Rev, 9 (3), pp. 275-308
• Rammes, G., Rupprecht, R., Ferrari, U., The N-methyl-D-aspartate receptor channel blockers memantine, MRZ 2/579 and other amino-alkyl-cyclohexanes antagonise 5-HT(3) receptor currents in cultured HEK-293 and N1E-115 cell systems in a non-competitive manner (2001) Neurosci Lett, 306 (1-2), pp. 81-84
• Oliver, D., Ludwig, J., Reisinger, E., Memantine inhibits efferent cholinergic transmission in the cochlea by blocking nicotinic acetylcholine receptors of outer hair cells (2001) Mol Pharmacol, 60 (1), pp. 183-189
• Lobarinas, E., Yang, G., Sun, W., Salicylate- and quinine-induced tinnitus and effects of memantine (2006) Acta Otolaryngol Suppl, (556), pp. 13-19
• Figueiredo, R.R., Langguth, B., De Oliveira, P.M., De Azevedo, A.A., Tinnitus treatment with memantine (2008) Otolaryngol Head Neck Surg, 138 (4), pp. 492-496
• Salembier, L., De Ridder, D., Van De Heyning, P.H., The use of flupirtine in treatment of tinnitus (2006) Acta Otolaryngol Suppl, 556, pp. 93-95
• Williams, S.H., Medications for treating alcohol dependence (2005) Am Fam Physician, 72 (9), pp. 1775-1780
• Azevedo, A.A., Figueiredo, R.R., Treatment of tinnitus with acamprosate (2007) Prog Brain Res, 166, pp. 273-277
• http://clinicaltrials.gov/ct2/show/NCT00596531, Available from:; Jastreboff, P.J., Hazell, J.W., A neurophysiological approach to tinnitus: Clinical implications (1993) Br J Audiol, 27 (1), pp. 7-17
• Lockwood, A.H., Salvi, R.J., Coad, M.L., The functional neuroanatomy of tinnitus: Evidence for limbic system links and neural plasticity (1998) Neurology, 50 (1), pp. 114-120
• Larson, E.R., Ariano, M.A., D3 and D2 dopamine receptors: Visualization of cellular expression patterns in motor and limbic structures (1995) Synapse, 20 (4), pp. 325-337
• Memo, M., Battaini, F., Spano, P.F., Trabucchi, M., Sulpiride and the role of dopaminergic receptor blockade in the antipsychotic activity of neuroleptics (1981) Acta Psychiatr Scand, 63 (4), pp. 314-324
• Lopez-Gonzalez, M.A., Santiago, A.M., Esteban-Ortega, F., Sulpiride and melatonin decrease tinnitus perception modulating the auditolimbic dopaminergic pathway (2007) J Otolaryngol, 36 (4), pp. 213-219
• Lopez-Gonzalez, M.A., Moliner-Peiro, F., Faro-Garcia, J., Esteban-Ortega, F., Sulpiride plus hydroxyzine decrease tinnitus perception (2007) Auris Nasus Larynx, 34 (1), pp. 23-27
• Hastak, S.M., Treatment of memory impairment, vertigo and tinnitus in the elderly with piribedil in an Indian general practice setting (2003) J Indian Med Assoc, 101 (8), pp. 500-501
• Slattery, W.H., Fisher, L.M., Iqbal, Z., Friedman, R.A., Liu, N., Intratympanic steroid injection for treatment of idiopathic sudden hearing loss (2005) Otolaryngology - Head and Neck Surgery, 133 (2), pp. 251-259. , DOI 10.1016/j.otohns.2005.05.015, PII S0194599805005802
• Azevedo, A.A., Langguth, B., De Oliveira, P.M., Figueiredo, R.R., Tinnitus treatment with piribedil guided by electrocochleography and acoustic otoemisions (2009) Otol Neurotol in Press
• Slattery, W.H., Fisher, L.M., Iqbal, Z., Liu, N., Oral steroid regimens for idiopathic sudden sensorineural hearing loss (2005) Otolaryngology - Head and Neck Surgery, 132 (1), pp. 5-10. , DOI 10.1016/j.otohns.2004.09.072, PII S0194599804018558
• Haynes, D.S., O'Malley, M., Cohen, S., Intratympanic dexamethasone for sudden sensorineural hearing loss after failure of systemic therapy (2007) Laryngoscope, 117 (1), pp. 3-15
• Wei, B.P.C., Mubiru, S., O'Leary, S., Steroids for idiopathic sudden sensorineural hearing loss (2006) Cochrane Database Syst Rev, (1)
• Mahadevan, S., Park, Y., Multifaceted therapeutic benefits of Ginkgo biloba L: Chemistry, efficacy, safety, and uses (2008) J Food Sci, 73 (1), pp. R14-R19
• Morgenstern, C., Biermann, E., The efficacy of Ginkgo special extract EGb 761 in patients with tinnitus (2002) Int J Clin Pharmacol Ther, 40 (5), pp. 188-197
• Holstein, N., Ginkgo special extract EGb 761 in tinnitus therapy. An overview of results of completed clinical trials (2001) Fortschr Med Orig, 118, pp. 157-164
• Drew, S., Davies, E., Effectiveness of Ginkgo biloba in treating tinnitus: Double blind, placebo controlled trial (2001) BMJ, 322 (7278), p. 73
• Rejali, D., Sivakumar, A., Balaji, N., Ginkgo biloba does not benefit patients with tinnitus: A randomized placebo-controlled double-blind trial and meta-analysis of randomized trials (2004) Clin Otolaryngol Allied Sci, 29 (3), pp. 226-231
• Hilton, M., Stuart, E., Ginkgo biloba for tinnitus (2004) Cochrane Database Syst Rev, 2, pp. CD003852
• Jan, J.E., Reiter, R.J., Wasdell, M.B., Bax, M., The role of the thalamus in sleep, pineal melatonin production, and circadian rhythm sleep disorders (2009) J Pineal Res, 46 (1), pp. 1-7
• Seggie, J., Werstiuk, E.S., Grota, L., Lithium and circadian patterns of melatonin in the retina, hypothalamus, pineal and serum (1987) Prog Neuropsychopharmacol Biol Psychiatry, 11 (2-3), pp. 325-334
• Berra, B., Rizzo, A.M., Melatonin: Circadian rhythm regulator, chronobiotic, antioxidant and beyond (2009) Clin Dermatol, 27 (2), pp. 202-209
• Lopez-Gonzalez, M.A., Guerrero, J.M., Rojas, F., Delgado, F., Ototoxicity caused by cisplatin is ameliorated by melatonin and other antioxidants (2000) J Pineal Res, 28 (2), pp. 73-80
• Bas, E., Martinez-Soriano, F., Lainez, J.M., Marco, J., An experimental comparative study of dexamethasone, melatonin and tacrolimus in noise-induced hearing loss (2009) Acta Otolaryngol, 129 (4), pp. 385-389
• Megwalu, U.C., Finnell, J.E., Piccirillo, J.F., The effects of melatonin on tinnitus and sleep (2006) Otolaryngol Head Neck Surg, 134 (2), pp. 210-213
• Rosenberg, S.I., Silverstein, H., Rowan, P.T., Olds, M.J., Effect of melatonin on tinnitus (1998) Laryngoscope, 108 (3), pp. 305-310
• McFadden, S.L., Ding, D., Burkard, R.F., Cu/Zn SOD deficiency potentiates hearing loss and cochlear pathology in aged 129,CD-1 mice (1999) J Comp Neurol, 413 (1), pp. 101-112
• Zirpel, L., Parks, T.N., Zinc inhibition of group i mGluR-mediated calcium homeostasis in auditory neurons (2001) J Assoc Res Otolaryngol, 2 (2), pp. 180-187
• Shambaugh, G.E., Zinc for tinnitus, imbalance, and hearing loss in the elderly (1986) Am J Otol, 7 (6), pp. 476-477
• Coelho, C.B., Tyler, R., Hansen, M., Zinc as a possible treatment for tinnitus (2007) Prog Brain Res, 166, pp. 279-285
• Paaske, P.B., Pedersen, C.B., Kjems, G., Sam, I.L., Zinc in the management of tinnitus. Placebo-controlled trial (1991) Ann Otol Rhinol Laryngol, 100 (8), pp. 647-649
• Yetiser, S., Tosun, F., Satar, B., The role of zinc in management of tinnitus (2002) Auris Nasus Larynx, 29 (4), pp. 329-333
• Roth, S.H., Misoprostol in the prevention of NSAID-induced gastric ulcer: A multicenter, double-blind, placebo-controlled trial (1990) J Rheumatol Suppl, 20, pp. 20-24
• Briner, W., House, J., O'Leary, M., Synthetic prostaglandin E1 misoprostol as a treatment for tinnitus (1993) Arch Otolaryngol Head Neck Surg, 119 (6), pp. 652-654
• Yilmaz, I., Akkuzu, B., Cakmak, O., Ozluoglu, L.N., Misoprostol in the treatment of tinnitus: A double-blind study (2004) Otolaryngol Head Neck Surg, 130 (5), pp. 604-610
• Gresser, U., Gathof, B.S., Atorvastatin: Gold standard for prophylaxis of myocardial ischemia and stroke - Comparison of the clinical benefit of statins on the basis of randomized controlled endpoint studies (2004) Eur J Med Res, 9 (1), pp. 1-17
• Olzowy, B., Canis, M., Hempel, J.M., Effect of atorvastatin on progression of sensorineural hearing loss and tinnitus in the elderly: Results of a prospective, randomized, double-blind clinical trial (2007) Otol Neurotol, 28 (4), pp. 455-458
• Scriabine, A., Van Den, K.W., Pharmacology of nimodipine. A review (1988) Ann NY Acad Sci, 522, pp. 698-706
• Keyrouz, S.G., Diringer, M.N., Clinical review: Prevention and therapy of vasospasm in subarachnoid hemorrhage (2007) Crit Care, 11 (4), p. 220
• Goodnick, P.J., Nimodipine treatment of rapid cycling bipolar disorder (1995) J Clin Psychiatry, 56 (7), p. 330
• Jastreboff, P.J., Brennan, J.F., Sasaki, C.T., Quinine-induced tinnitus in rats (1991) Arch Otolaryngol Head Neck Surg, 117 (10), pp. 1162-1166
• Theopold, H.M., Nimodipine (Bay e 9736) a new therapy concept in diseases of the inner ear? (1985) Laryngol Rhinol Otol (Stuttg), 64 (12), pp. 609-613
• Davies, E., Knox, E., Donaldson, I., The usefulness of nimodipine, an L-calcium channel antagonist, in the treatment of tinnitus (1994) Br J Audiol, 28 (3), pp. 125-129
• Hutcheon, D.E., Leonard, G., Diuretic and antihypertensive actions of furosemide (1967) J Clin Pharmacol J New Drugs, 7 (1), pp. 26-33
• Shiozaki, A., Miyazaki, H., Niisato, N., Furosemide, a blocker of Na+/K+/2Cl-cotransporter, diminishes proliferation of poorly differentiated human gastric cancer cells by affecting G0/G1 state (2006) J Physiol Sci, 56 (6), pp. 401-406
• Sakaguchi, N., Crouch, J.J., Lytle, C., Schulte, B.A., Na-K-Cl cotransporter expression in the developing and senescent gerbil cochlea (1998) Hear Res, 118 (1-2), pp. 114-122
• Chen, H., Sun, D., The role of Na-K-Cl co-transporter in cerebral ischemia (2005) Neurol Res, 27 (3), pp. 280-286
• Rybak, L.P., Morizono, T., Effect of furosemide upon endolymph potassium concentration (1982) Hear Res, 7 (2), pp. 223-231
• Futaki, T., Kitahara, M., Morimoto, M., A comparison of the furosemide and glycerol tests for Meniere's disease. With special reference to the bilateral lesion (1977) Acta Otolaryngol, 83 (3-4), pp. 272-278
• Kuchar, D.L., O'Rourke, M.F., High dose furosemide in refractory cardiac failure (1985) Eur Heart J, 6 (11), pp. 954-958
• Ho, K.M., Sheridan, D.J., Meta-analysis of frusemide to prevent or treat acute renal failure (2006) BMJ, 333 (7565), p. 420
• Filipo, R., Barbara, M., Cordier, A., Osmotic drugs in the treatment of cochlear disorders: A clinical and experimental study (1997) Acta Otolaryngol, 117 (2), pp. 229-231
• McCabe, B.F., Central aspects of drugs for motion sickness and vertigo (1973) Adv Otorhinolaryngol, 20, pp. 458-469
• Kranke, P., Morin, A.M., Roewer, N., Wulf, H., Eberhart, L.H., The efficacy and safety of transdermal scopolamine for the prevention of postoperative nausea and vomiting: A quantitative systematic review (2002) Anesthesia and Analgesia, 95 (1), pp. 133-143
• Wallhausser-Franke, E., Cuautle-Heck, B., Scopolamine attenuates tinnitus-related plasticity in the auditory cortex (2006) Neuroreport, 17 (14), pp. 1487-1491
• Lobarinas, E., Sun, W., Stolzberg, D., Human brain imaging of tinnitus and animal models (2008) Semin Hear, 29 (4), pp. 333-349
• Timmerman, H., Calcium modulation and clinical effect. Profile of cyclandelate (1987) Drugs, 33 (SUPPL. 2), pp. 1-4
• Memin, Y., Perceived efficacy of cyclandelate in the treatment of cochleovestibular and retinal disturbances related to cerebrovascular insufficiency (1987) Drugs, 33 (SUPPL.), pp. 120-124. , A study in general practice comprising 2772 patients
• Hester, T.O., Theilman, G., Green, W., Jones, R.O., Cyclandelate in the management of tinnitus: A randomized, placebo-controlled study (1998) Otolaryngol Head Neck Surg, 118 (3 PART 1), pp. 329-332
• Stidham, K.R., Solomon, P.H., Roberson, J.B., Evaluation of botulinum toxin A in treatment of tinnitus (2005) Otolaryngol Head Neck Surg, 132 (6), pp. 883-889
• Penney, S.E., Bruce, I.A., Saeed, S.R., Botulinum toxin is effective and safe for palatal tremor: A report of five cases and a review of the literature (2006) J Neurol, 253 (7), pp. 857-860
• Adjamian, P., Sereda, M., Hall, D.A., The mechanisms of tinnitus: Perspectives from human functional neuroimaging (2009) Hear Res, 253, pp. 15-31
• Turner, J.G., Behavioral measures of tinnitus in laboratory animals (2007) Prog Brain Res, 166, pp. 147-156
• Arnold, W., Bartenstein, P., Oestreicher, E., Focal metabolic activation in the predominant left auditory cortex in patients suffering from tinnitus: A PET study with [18F]deoxyglucose (1996) ORL J Otorhinolaryngol Relat Spec, 58, pp. 195-199
• Muhlnickel, W., Elbert, T., Taub, E., Flor, H., Reorganization of auditory cortex in tinnitus (1998) Proc Natl Acad Sci USA, 95, pp. 10340-10343
• Sun, W., Lu, J., Stolzberg, D., Salicylate increases the gain of the central auditory system (2009) Neuroscience, 159 (1), pp. 325-334
• Moller, A.R., The role of neural plasticity in tinnitus (2007) Prog Brain Res, 166, pp. 37-45
• De Ridder, D., Verstraeten, E., Van Der, K.K., Transcranial magnetic stimulation for tinnitus: Influence of tinnitus duration on stimulation parameter choice and maximal tinnitus suppression (2005) Otol Neurotol, 26 (4), pp. 616-619
• De Ridder, D., Van Der Loo, E., Van Der Kelen, K., Do tonic and burst TMS modulate the lemniscal and extralemniscal system differentially? (2007) Int J Med Sci, 4 (5), pp. 242-246
• Tyler, R., Coelho, C., Tao, P., Identifying tinnitus subgroups with cluster analysis (2008) Am J Audiol, 17 (2), pp. S176-S184
• Tyler, R.S., Oleson, J., Noble, W., Clinical trials for tinnitus: Study populations, designs, measurement variables, and data analysis (2007) Prog Brain Res, 166, pp. 499-509
• Elgoyhen, A.B., Vetter, D.E., Katz, E., Alpha10: A determinant of nicotinic cholinergic receptor function in mammalian vestibular and cochlear mechanosensory hair cells (2001) Proc Natl Acad Sci USA, 98 (6), pp. 3501-3506
• Elgoyhen, A.B., Johnson, D.S., Boulter, J., Alpha 9: An acetylcholine receptor with novel pharmacological properties expressed in rat cochlear hair cells (1994) Cell, 79 (4), pp. 705-715
• Plazas, P.V., Savino, J., Kracun, S., Inhibition of the alpha9alpha10 nicotinic cholinergic receptor by neramexane, an open channel blocker of N-methyl-D-aspartate receptors (2007) Eur J Pharmacol, 566 (1-3), pp. 11-19
• http://clinicaltrials.gov/ct2/show/NCT00405886, Available from:; http://clinicaltrials.gov/ct2/show/NCT00739635, Available from: http://clinicaltrials.gov/ct2/show/NCT00772980, http://clinicaltrials.gov/ct2/show/NCT00827008; http://clinicaltrials.gov/ct2/show/NCT00860808, Available from:; Sun, W., Ding, D.L., Wang, P., Substance P inhibits potassium and calcium currents in inner ear spiral ganglion neurons (2004) Brain Res, 1012 (1-2), pp. 82-92
• http://clinicaltrials.gov/ct2/show/NCT00394056, Available from:; Carpenter, W.T., Koenig, J.I., The evolution of drug development in schizophrenia: Past issues and future opportunities (2008) Neuropsychopharmacology, 33 (9), pp. 2061-2079
• De Ridder, D., Fransen, H., Francois, O., Amygdalohippocampal involvement in tinnitus and auditory memory (2006) Acta Otolaryngol Suppl, 556, pp. 50-53
• Yang, G., Lobarinas, E., Zhang, L., Salicylate induced tinnitus: Behavioral measures and neural activity in auditory cortex of awake rats (2007) Hear Res, 226 (1-2), pp. 244-253
• Lobarinas, E., Sun, W., Cushing, R., Salvi, R., A novel behavioral paradigm for assessing tinnitus using schedule-induced polydipsia avoidance conditioning (SIP-AC) (2004) Hear Res, 190 (1-2), pp. 109-114
• Hurko, O., Ryan, J.L., Translational research in central nervous system drug discovery (2005) Neuro Rx, 2 (4), pp. 671-682
• Meikle, M.B., Vernon, J., Johnson, R.M., The perceived severity of tinnitus. Some observations concerning a large population of tinnitus clinic patients (1984) Otolaryngol Head Neck Surg, 92 (6), pp. 689-696
• Jakes, S.C., Hallam, R.S., Chambers, C., Hinchcliffe, R., A factor analytical study of tinnitus complaint behaviour (1985) Audiology, 24 (3), pp. 195-206
• Newman, C.W., Sandridge, S.A., Jacobson, G.P., Psychometric adequacy of the Tinnitus Handicap Inventory (THI) for evaluating treatment outcome (1998) J Am Acad Audiol, 9 (2), pp. 153-160
• Goebel, G., Hiller, W., The tinnitus questionnaire. A standard instrument for grading the degree of tinnitus. Results of a multicenter study with the tinnitus questionnaire (1994) Hno, 42, pp. 166-172
• Kuk, F.K., Tyler, R.S., Russell, D., Jordan, H., The psychometric properties of a tinnitus handicap questionnaire (1990) Ear Hear, 11 (6), pp. 434-445

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------